Halozyme Therapeutics | 판매 및 관리 비용





판매 및 관리 비용 변화 날짜
Acadia Pharmaceuticals USD 124.9M 1.24M 2025-09
Agios Pharmaceuticals USD 42.97M 1.7M 2025-12
Alnylam Pharmaceuticals USD 285.06M 22.47M 2025-12
Amarin USD 17.94M 17.86M 2025-09
Amgen USD 1.94B 237M 2025-12
Baxter International USD 761M 53M 2025-12
Cara Therapeutics USD 4.64M 2.19M 2025-03
Cytokinetics USD 158.75M 93.03M 2025-09
DBV Technologies USD 3.63M 3.18M 2025-09
Eli Lilly USD 3.13B 391.3M 2025-12
Esperion Therapeutics USD 39.98M 4.21M 2024-09
Halozyme Therapeutics USD 64.64M 27.11M 2025-12
Intrexon USD 10.31M 41K 2024-06
Ionis Pharmaceuticals USD 86.56M 4.04M 2025-09
MannKind USD 29.09M 2.53M 2025-09
Minerva Neurosciences USD 2.48M 58.79K 2024-09
Nektar Therapeutics USD -0.18 0.07 2024-09
Pfizer USD 4.08B 894M 2025-12
Rigel Pharmaceuticals USD 27.04M 1M 2024-09
United Therapeutics USD 152M 60.5M 2025-09
Vanda Pharmaceuticals USD 39.28M 1.71M 2024-12


Halozyme Therapeutics 판매 및 관리 비용 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Feb 2026.